Affiliation:
1. University of Washington Seattle WA
2. Division of Research Kaiser Permanente Northern California Oakland CA
3. Tulane University New Orleans LA
4. University of Maryland Baltimore MD
5. University of Pennsylvania Philadelphia PA
6. Inova Health System Falls Church VA
7. University of Illinois, Chicago IL
8. Wake Forest University Winston‐Salem NC
9. University of California, San Francisco San Francisco CA
Abstract
Background
Cardiac biomarkers may signal mechanistic pathways involved in heart failure (
HF
), a leading complication in chronic kidney disease. We tested the associations of NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide), high‐sensitivity troponin T (hsTnT), galectin‐3, growth differentiation factor‐15 (
GDF
‐15), and soluble
ST
2 (
sST
2) with incident
HF
in chronic kidney disease.
Methods and Results
We examined adults with chronic kidney disease enrolled in a prospective, multicenter study. All biomarkers were measured at baseline. The primary outcome was incident
HF
. Secondary outcomes included
HF
with preserved ejection fraction (EF≥50%) and reduced ejection fraction (EF<50%). Cox models were used to test the association of each cardiac biomarker with
HF
, adjusting for demographics, kidney function, cardiovascular risk factors, and medication use. Among 3314 participants, all biomarkers, with the exception of galectin‐3, were significantly associated with increased risk of incident
HF
(hazard ratio per SD higher concentration of log‐transformed biomarker):
NT
‐pro
BNP
(hazard ratio, 2.07; 95%
CI
, 1.79–2.39); hsTnT (hazard ratio, 1.38; 95%
CI
, 1.21–1.56);
GDF
‐15 (hazard ratio, 1.44; 95%
CI
, 1.26–1.66) and
sST
2 (hazard ratio, 1.19; 95% CI, 1.05–1.35). Higher
NT
‐pro
BNP
, hsTnT, and
GDF
‐15 were also associated with a greater risk of
HF
with reduced
EF
; while higher
NT
‐pro
BNP GDF
‐15 and
sST
2 were associated with
HF
with preserved
EF
. Galectin‐3 was not associated with either HF with reduced
EF
or
HF
with preserved EF.
Conclusions
In chronic kidney disease, elevations of
NT
‐pro
BNP
, hsTnT,
GDF
‐15,
sST
2 were associated with incident
HF
. There was a borderline association of galectin‐3 with incident
HF
.
NT
‐pro
BNP
and hsTnT were more strongly associated with
HF
with reduced
EF
, while the associations of the newer biomarkers
GDF
‐15 and
sST
2 were stronger for
HF
with preserved EF.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献